Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

NCT02958969 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism
Multiple Myeloma

Interventions

DRUG: Apixaban

Sponsor

Gregory Piazza

Collaborators

[object Object]